Cargando…

Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis

BACKGROUND: The neuropathological process underlying amyotrophic lateral sclerosis (ALS) can be traced as a four-stage progression scheme of sequential corticofugal axonal spread. The examination of eye movement control gains deep insights into brain network pathology and provides the opportunity to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorges, Martin, Müller, Hans-Peter, Lulé, Dorothée, Del Tredici, Kelly, Brettschneider, Johannes, Keller, Jürgen, Pfandl, Katharina, Ludolph, Albert C., Kassubek, Jan, Pinkhardt, Elmar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641606/ https://www.ncbi.nlm.nih.gov/pubmed/26559944 http://dx.doi.org/10.1371/journal.pone.0142546

Ejemplares similares

Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis
por: Schulthess, Ines, et al.
Publicado: (2016)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
por: Tan, Rachel H., et al.
Publicado: (2023)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018)

Atypical astroglial pTDP‐43 pathology in astroglial predominant tauopathy
por: Gelpi, Ellen, et al.
Publicado: (2021)

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
por: Kassubek, Jan, et al.
Publicado: (2018)

Alterations of Eye Movement Control in Neurodegenerative Movement Disorders
por: Gorges, Martin, et al.
Publicado: (2014)

Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms
por: Pinkhardt, Elmar H, et al.
Publicado: (2012)

Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence
por: Behler, Anna, et al.
Publicado: (2022)

Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal α-motoneurons in sporadic amyotrophic lateral sclerosis
por: Braak, Heiko, et al.
Publicado: (2016)

Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry
por: Pinkhardt, Elmar H, et al.
Publicado: (2006)

Eye movement alterations in presymptomatic C9orf72 expansion gene carriers
por: Behler, Anna, et al.
Publicado: (2021)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis
por: Riemslagh, Frederike W., et al.
Publicado: (2019)

pTDP‐43 aggregates accumulate in non‐central nervous system tissues prior to symptom onset in amyotrophic lateral sclerosis: a case series linking archival surgical biopsies with clinical phenotypic data
por: Pattle, Samuel B, et al.
Publicado: (2022)

Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data
por: Gorges, Martin, et al.
Publicado: (2018)

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies
por: Behler, Anna, et al.
Publicado: (2022)

A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis
por: Behler, Anna, et al.
Publicado: (2022)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
por: Schrempf, Till, et al.
Publicado: (2021)

TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)

Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level
por: Aho-Özhan, Helena E. A., et al.
Publicado: (2016)

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017)

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020)

Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43
por: Kitamura, Akira, et al.
Publicado: (2023)

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
por: Gruijs da Silva, Lara A, et al.
Publicado: (2022)

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
por: Guerreiro, Rita J., et al.
Publicado: (2008)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
por: Prasad, Archana, et al.
Publicado: (2019)

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
por: Nielsen, Anne Kallehauge, et al.
Publicado: (2020)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
por: Murakami, Aya, et al.
Publicado: (2022)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study
por: Müller, Hans-Peter, et al.
Publicado: (2018)

The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis
por: Wang, Xinxin, et al.
Publicado: (2023)

The same cortico-efferent tract involvement in progressive bulbar palsy and in ‘classical’ ALS: A tract of interest-based MRI study
por: Müller, Hans-Peter, et al.
Publicado: (2019)

In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study
por: Müller, Hans-Peter, et al.
Publicado: (2020)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0re5ffimj39tca9sga2qas6jq